Richard Alonso

2.1k total citations
40 papers, 1.6k citations indexed

About

Richard Alonso is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Behavioral Neuroscience. According to data from OpenAlex, Richard Alonso has authored 40 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 26 papers in Cellular and Molecular Neuroscience and 4 papers in Behavioral Neuroscience. Recurrent topics in Richard Alonso's work include Receptor Mechanisms and Signaling (18 papers), Neuroscience and Neuropharmacology Research (12 papers) and Neuropeptides and Animal Physiology (12 papers). Richard Alonso is often cited by papers focused on Receptor Mechanisms and Signaling (18 papers), Neuroscience and Neuropharmacology Research (12 papers) and Neuropeptides and Animal Physiology (12 papers). Richard Alonso collaborates with scholars based in France, Canada and United States. Richard Alonso's co-authors include Philippe Soubrié, G. Le Fur, Guy Griebel, Jeanne Stemmelin, Gérard Le Fur, G Pavone, P. Soubrié, Walter B. Dandliker, Michel Héaulme and Rémi Quirion and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Neuroscience and Neuroscience.

In The Last Decade

Richard Alonso

40 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Alonso France 19 794 549 419 274 167 40 1.6k
Lawrence W. Fitzgerald United States 23 944 1.2× 649 1.2× 200 0.5× 334 1.2× 152 0.9× 42 2.0k
Xiao‐Ming Ou United States 27 823 1.0× 789 1.4× 240 0.6× 299 1.1× 184 1.1× 40 2.2k
Eric Ronken Netherlands 23 824 1.0× 919 1.7× 195 0.5× 265 1.0× 298 1.8× 44 2.1k
Carina Stenfors Sweden 27 1.1k 1.4× 658 1.2× 154 0.4× 305 1.1× 230 1.4× 66 1.8k
Albert Sattin United States 22 1.0k 1.3× 792 1.4× 183 0.4× 245 0.9× 155 0.9× 61 2.0k
Patrizia Longone Italy 31 913 1.1× 881 1.6× 239 0.6× 126 0.5× 73 0.4× 63 2.6k
Carrol D’Sa United States 14 772 1.0× 430 0.8× 203 0.5× 340 1.2× 103 0.6× 15 1.6k
Clotilde Mannoury la Cour France 26 1.2k 1.5× 993 1.8× 211 0.5× 131 0.5× 187 1.1× 48 1.9k
Cristina Cosi France 27 1.1k 1.4× 939 1.7× 145 0.3× 88 0.3× 100 0.6× 51 2.1k
Philip L. Mobley United States 19 620 0.8× 537 1.0× 215 0.5× 185 0.7× 77 0.5× 31 1.2k

Countries citing papers authored by Richard Alonso

Since Specialization
Citations

This map shows the geographic impact of Richard Alonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Alonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Alonso more than expected).

Fields of papers citing papers by Richard Alonso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Alonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Alonso. The network helps show where Richard Alonso may publish in the future.

Co-authorship network of co-authors of Richard Alonso

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Alonso. A scholar is included among the top collaborators of Richard Alonso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Alonso. Richard Alonso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Griebel, Guy, Sandra Beeské, Richard Alonso, et al.. (2013). Further evidence for the sleep-promoting effects of 5-HT2A receptor antagonists and demonstration of synergistic effects with the hypnotic, zolpidem in rats. Neuropharmacology. 70. 19–26. 13 indexed citations
3.
Claustre, Y., Philippe Brun, Christiane Gueudet, et al.. (2003). SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological Profile. Neuropsychopharmacology. 28(12). 2064–2076. 41 indexed citations
4.
Alonso, Richard, Guy Griebel, G Pavone, et al.. (2003). Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression. Molecular Psychiatry. 9(3). 278–286. 270 indexed citations
7.
Alonso, Richard, Marie Fournier, R. Steinberg, et al.. (1999). Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function. Neuroscience. 91(2). 607–620. 73 indexed citations
8.
Steinberg, R., M. Bensaïd, J. Souilhac, et al.. (1998). Expression and presence of septal neurokinin‐2 receptors controlling hippocampal acetylcholine release during sensory stimulation in rat. European Journal of Neuroscience. 10(7). 2337–2345. 35 indexed citations
9.
Steinberg, R., J. Souilhac, Richard Alonso, et al.. (1998). Facilitation of striatal acetylcholine release by dopamine D1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation. Neuroscience. 84(2). 511–518. 29 indexed citations
10.
Sarrieau, Alain, Dajan O’Donnell, Richard Alonso, & Michael J. Meaney. (1996). Regulation of glucocorticosteroid receptor expression in rat hippocampal cell cultures by nerve growth factor. Neuroscience Letters. 206(2-3). 207–211. 12 indexed citations
11.
Alonso, Richard, et al.. (1996). Evidence for Modulation of DoDamine‐neuronal Function by Tachykinin NK3 Receptor Stimulation in Gerbil Mesencephalic Cell Cultures. European Journal of Neuroscience. 8(4). 801–808. 25 indexed citations
12.
Poirier, Judes, Uwe Beffert, Doris Dea, et al.. (1995). Increased levels of statin, a marker of cell cycle arrest, in response to hippocampal neuronal injury. Molecular Brain Research. 34(1). 57–64. 1 indexed citations
13.
Rinaldi‐Carmona, Murielle, Francis Barth, Michel Héaulme, et al.. (1995). Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sciences. 56(23-24). 1941–1947. 269 indexed citations
14.
Alonso, Richard, Judes Poirier, D. O'Donnell, et al.. (1994). Statin, a Marker of Cell Cycle Arrest, Is Overexpressed during the Early Phase of Delayed NMDA Toxicity in Hippocampal Cell Cultures. Molecular and Cellular Neuroscience. 5(6). 530–539. 4 indexed citations
15.
Klink, Ruby & Richard Alonso. (1992). Serotoninergic and cholinergic concert actions on entorhinal cortex layer II neurons An in vitro study. The Society for Neuroscience Abstracts. 18. 749. 1 indexed citations
16.
Chaudieu, Isabelle, Richard Alonso, Howard T.J. Mount, Rémi Quirion, & Patricia Boksa. (1992). Effects of L- and N-type Ca2+ channel antagonists on excitatory amino acid-evoked dopamine release. European Journal of Pharmacology. 220(2-3). 203–209. 17 indexed citations
17.
Alonso, Richard & Philippe Soubrié. (1991). Effects of serotonergic denervation on the density and plasticity of brain muscarinic receptors in the rat. Synapse. 8(1). 30–37. 12 indexed citations
18.
Alonso, Richard, Michel Didier, & Philippe Soubrié. (1990). [3H]N‐Methylscopolamine Binding Studies Reveal M2 and M3 Muscarinic Receptor Subtypes on Cerebellar Granule Cells in Primary Culture. Journal of Neurochemistry. 55(1). 334–337. 17 indexed citations
19.
Alonso, Richard, J.P. Kan, P. Worms, & Philippe Soubrié. (1990). Effects of repeated administration of tetrahydroaminoacridine (THA) on muscarinic receptor subtypes in the rat brain. Neurochemistry International. 17(3). 457–465. 5 indexed citations
20.
Dandliker, Walter B., et al.. (1965). STUDY OF PENICILLIN ANTIBODIES BY FLUORESCENCE POLARIZATION AND IMMUNODIFFUSION. The Journal of Experimental Medicine. 122(6). 1029–1048. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026